Navigation Links
Herborium Announces Continuing Progress In Key Strategic Initiatives
Date:5/4/2012

TEANECK, N.J., May 4, 2012 /PRNewswire/ -- Herborium Group, Inc., (PINKS. HBRM) www.herborium.com, a Botanical Therapeutics® company, reports today continuing progress with its key strategic initiatives.

The company is progressing through the negotiating phase with China Health Resource Inc. regarding a potential acquisition. Both, Herborium Group and China Resource continue to work diligently towards a successful transaction.      

Herborium's partnership with KAMASUTRA (USA), LLC  to commercialize their unique vodka product containing Herborium's proprietary herbal formula  derived from the Company's sexual health formulations, has moved into the introductory marketing phase with the digital marketing plan to be initiated in June 2012.  Market share for vodka in the US is $4.8 Billion in annual sales with both on premise and home consumption on the rise.  KAMASUTRA (USA) LLC is the US partner of the German Bismarck Premium Brands GmbH  www.bismarck.de  and http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.

The market for pharmaceutical sexual health products is over $3.2 billion worldwide. The market for natural sexual health products is estimated to be over $1.5 billion, and growing.

Dr. Agnes P. Olszewski, CEO of Herborium, recently completed the National Publicity Summit in New York City (April 25-29, 2012). The Company is looking forward to multiple media exposure opportunities resulting from this Summit  that shall greatly elevate  Herborium's  public awareness.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company markets its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Group Shareholders Update
2. Bacterin Announces First Quarter 2012 Revenue of $7.8 Million, Up 29% Year-over-Year, on Gross Margins of 76%, and 34% Reduction in Operating Loss
3. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
4. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
5. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
6. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
7. Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
8. Hill-Rom Announces Third Quarter 2012 Dividend
9. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
10. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
11. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , January 24, 2017 ... dem Molecular Surgical Laboratory des Massachusetts General Hospital (MGH) ... Dabei geht es um die Identifizierung und Validierung neuartiger ... Ansätzen, dass sie der Resistenz von Antibiotika bei der ... ...
(Date:1/24/2017)... 2017 Scope of the Report The ... Intermittent Catheter Market (2016-2020)", provides an in-depth analysis of ... by product line. The market also provides an in-depth ... report provides a regional analysis of continence care market, ... , Europe and Rest of ...
(Date:1/23/2017)... WASHINGTON , Jan. 23, 2017 ... to suspend the implementation of the planned 2020 ... PTCB Certification. PTCB originally announced in 2013 that ... part of a road map of program changes ... technician roles in the pharmacy. ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... Manzo Pharmaceuticals, LLC., ... a Registered Trademark by the United States Patent and Trademark Office. The ... could confuse consumers into thinking that other products are similar to the patented ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... detect, and eliminate cyber threats in real-time, today announced a strategic partnership with ... enable customers to monitor, respond and protect their critical information assets and infrastructure, ...
(Date:1/24/2017)... ... January 24, 2017 , ... Bellus Medical, a leader ... of medical experts. In his new role Dr. Dobke will provide physician oversight for ... Dobke is the Head of Plastic Surgery and Associate Professor of Surgery at UC ...
(Date:1/24/2017)... IA (PRWEB) , ... January 24, 2017 , ... The ... country, has taken great care to design a program that provides teachers with the ... and domestically. This online teaching certificate is ideal for post-baccalaureate students and HigherEducation.com is ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... http://www.faculty.washington.edu/ghp , Sharon Kleyne, the nation’s foremost water advocate and host ... Change and Your Health on Voice America, once again welcomed one of her ...
Breaking Medicine News(10 mins):